StockData
Nanobiotix S.A. logo

Nanobiotix S.A. (NBTX) stock

NBTXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NNBXF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$26.50−0.82 (-2.98%)

Close on Nov 20, 2026Market cap $1.28BP/E –Yield –

Nanobiotix free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was -€33.96M. The highest annual figure on record is -€12.80M in fiscal 2023.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-€33.96M–
FY2024Dec 31, 2024-€20.40M–
FY2023Dec 31, 2023-€12.80M–
FY2022Dec 31, 2022-€37.20M–
FY2021Dec 31, 2021-€30.10M–
FY2020Dec 31, 2020-€27.63M–
FY2019Dec 31, 2019-€42.26M–
FY2018Dec 31, 2018-€26.40M–

More Nanobiotix figures

See a number that looks wrong?